Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,905 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06842524RecruitingPhase 2
Dihydroartemisinin for PCOS: A Phase 2 Trial
This trial tests if dihydroartemisinin (a medicine derived from a plant) can help women with PCOS. It may improve hormone balance and menstrual cycles.
Xiamen, FujianAges 18–40 - NCT06935682RecruitingPhase 1
Safety study of Y-4 tablets in healthy volunteers
This trial tests the safety and how the body processes a new medicine called Y-4. Healthy adults ages 18 to 45 can join to help researchers understand how the drug works and if it has any side effects.
Beijing, Beijing MunicipalityAges 18–45 - NCT07199829Recruiting
Vitamin D and K for military healthcare workers
This study tests whether taking vitamin D3 and K2 supplements can improve health in military healthcare workers who have low vitamin D levels. If you qualify, you will stop any current vitamin D or K supplements and take the study supplement for 4.5 months.
Tacoma, WashingtonAges 18–69 - NCT07199946RecruitingPhase 1/Phase 2
Verapamil to protect insulin production in children with new type 1 diabetes
This study tests if verapamil (a common blood pressure medication) can help children newly diagnosed with type 1 diabetes keep making their own insulin for longer. It aims to preserve the body's own insulin-producing cells, which may reduce the amount of insulin injections needed.
JönköpingAges 4–9 - NCT06665438RecruitingPhase 3
Pain relief after knee arthroscopy: numbing injection with added medication
This trial tests whether adding dexmedetomidine to a numbing injection (bupivacaine) inside the knee joint provides better pain relief after arthroscopic ACL reconstruction. It aims to help patients recover more comfortably after surgery.
AsyutAges 18–65 - NCT07195175RecruitingPhase 1
Safety study of MAR002 in healthy men
This early-phase trial tests a new investigational drug called MAR002 in healthy men. The goal is to see how safe the drug is and how the body handles it before moving to larger studies.
Tempe, ArizonaAges 18–40 - NCT07196501RecruitingPhase 3
Study of a new add-on treatment for depression maintenance
This trial tests a new medication (NBI-1065845) added to your current antidepressant to see if it helps maintain improvement in depression. It is for people whose depression hasn't fully responded to their current oral antidepressant.
Oceanside, CaliforniaAges 18 years+ - NCT07193927RecruitingPhase 2
Testing a probiotic mix for fatty liver disease (MASLD)
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
Girona, GironaAges 18–75 - NCT07199270RecruitingPhase 1
Safety study of GR2303 in healthy adults
This trial tests a new drug called GR2303 to see if it is safe and how the body processes it. It is for healthy adults who have not used similar drugs before.
Beijing, Beijing MunicipalityAges 18–45 - NCT07196748RecruitingPhase 3
Icotrokinra for adults and teens with moderate to severe ulcerative colitis
This trial tests a new oral medication, icotrokinra, for people with moderately to severely active ulcerative colitis. It may be an option if you have not responded well enough to standard treatments or newer advanced therapies.
Chandler, ArizonaAges 12 years+ - NCT07201688RecruitingPhase 3
Extending the window for stroke clot-busting drug
This trial tests a clot-dissolving medication called rhTNK-tPA for people who had a stroke 4.5 to 24 hours ago. It aims to help those with certain types of blockages in the brain who are still having moderate to severe symptoms.
Puyang, HenanAges 18 years+ - NCT07197814Recruiting
Tolerance of a rice protein formula in children with cow's milk allergy
This study tests a new formula made from rice protein in children who have a cow's milk allergy. It checks if the rice formula is well-tolerated without causing allergic reactions.
NaplesAges 1 month–3 years - NCT07198139RecruitingPhase 1/Phase 2
Testing a new norovirus treatment in healthy adults
This trial tests an investigational medicine called CDI-988 to see if it can prevent or treat norovirus infection. Healthy adults will be intentionally exposed to a mild norovirus strain to see how the medicine works.
Decatur, GeorgiaAges 18–49 - NCT07202884RecruitingPhase 3
Orforglipron for Women with Stress Incontinence and Overweight
This study tests an oral medication called orforglipron to see if it helps women with stress urinary incontinence who are also overweight or have obesity. The medicine may reduce leaking episodes and also help with weight loss.
Birmingham, AlabamaAges 18 years+ - NCT07198555RecruitingPhase 1
Study of BBM-A101 for knee osteoarthritis
This trial tests a new medicine called BBM-A101 for people with moderate knee osteoarthritis. It aims to see if it is safe and helps reduce pain and improve function.
Shenzhen, GuangdongAges 40–75 - NCT07199309RecruitingPhase 2
Study of MAR001 for people with high triglycerides and remnant cholesterol
This study tests a new medicine called MAR001 in people with high triglycerides and remnant cholesterol, which are types of fats in the blood. It aims to see if the medicine can improve these levels while you stick to your usual diet and medications.
Chula Vista, CaliforniaAges 18–75 - NCT07201922RecruitingPhase 3
Can a new pill help slow lung changes in people with family risk?
This trial tests a new drug called nerandomilast to see if it can slow down early lung changes in people who have a close family member with a type of lung scarring called pulmonary fibrosis. You may join if you are 40 or older, have a parent, sibling, or child with this condition, and have early signs of lung changes on a CT scan.
Los Angeles, CaliforniaAges 40 years+ - NCT07201129RecruitingPhase 3
Cenerimod for Active Lupus Nephritis
This trial tests if an investigational drug called cenerimod can safely and effectively treat active lupus nephritis when added to your regular lupus medications. It's for people with recent kidney biopsy showing active lupus kidney disease and high protein in urine.
Doral, FloridaAges 18–75 - NCT07196722RecruitingPhase 2/Phase 3
Testing icotrokinra for moderate to severe Crohn's disease
This study tests a new medicine called icotrokinra for people with moderate to severe Crohn's disease who have not responded well to other treatments. It aims to see if icotrokinra can help reduce symptoms and improve gut health.
Chandler, ArizonaAges 18 years+ - NCT07193459RecruitingPhase 3
Study of an oral tablet for type 2 diabetes
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
Beijing, Beijing MunicipalityAges 18–75 - NCT06798948RecruitingPhase 2
Can a mix of herbs improve mild fatty liver?
This study is testing if a combination of four herbs (artichoke, milk thistle, turmeric, and licorice root) can help people with non-alcoholic mild to moderate fatty liver disease (also called metabolic-associated fatty liver disease). It's a randomized trial, meaning participants are assigned to either the herbal mix or a comparison group. This may offer a natural option to support liver health.
Hangzhou, Select...Ages 18–65 - NCT06937190Recruiting
Does creatine before sleep improve power in active women?
This study tests if taking a small dose of creatine before bed helps women who exercise regularly perform better on power-based activities like jumping and sprinting. It's designed for healthy, young women who already do resistance training and want to see if a simple supplement can boost their nighttime recovery and next-day performance.
Shabestar, East Azerbaijan ProvinceAges 18–25 - NCT06062953RecruitingPhase 2/Phase 3
Melatonin or low-dose quetiapine for insomnia in psychiatric disorders
This study tests if melatonin, a low dose of quetiapine, or a placebo can help people with a psychiatric condition who also have trouble sleeping. You may qualify if you have insomnia at least 3 times a week and your sleep problem has lasted 3 months or longer.
Copenhagen NVAges 16–64 - NCT07202481Recruiting
Fiber supplements for constipation in women
This trial tests if two types of fiber—one from chicory and one from a plant husk—can help women with constipation move food through their intestines faster. It aims to find a gentle, non-drug option that might work better than what you eat now.
Belo Horizonte, Minas GeraisAges 18–59
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,905 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.